Law360, New York (October 20, 2011, 3:05 PM ET) -- A federal judge on Monday levied roughly $55,000 in sanctions against Novartis Pharmaceuticals Corp. in a multidistrict litigation over allegedly concealed health risks associated with two bone cancer drugs, saying the plaintiffs' requested attorneys' fees were needlessly high.
Novartis had been sanctioned in May 2010 for failing to come clean about the fact that it advertised the drugs, Aredia and Zometa, in consumer magazines, and Monday's order reimbursed the plaintiffs for additional discovery undertaken to determine how extensive the consumer advertising was. Magistrate Judge Joe Brown...
Novartis Stuck With Sanctions In Bone Drug MDL
To view the full article, take a free trial now.
